M9 Key considerations and best practices for viral vaccine process development, scale-up and implementation at manufacturing scale including single use technologies
Using a combination of theory and hands-on instruction, participants will learn the following:
- Key best practices and methods for vaccine process development from upstream to downstream focusing on a viral vaccine platform.
Best practices of cell culturing in single use bioreactors for both adherent and suspension cells;
Optimization of filtration and purification technologies;
- How to integrate vaccine processes in a single use environment;
Understand challenges and integrate key considerations for optimal viral vaccine process development and transition to manufacturing Learn how to implement a single use technology based process for viral vaccines.
Who should apply
Prior experience with laboratory scale vaccine and/or biologics process development.
Accommodation will be provided. Travel costs are not included.
Process development and scale-up of viral vaccines.
1 May 2021
Q3 2021 (2 days)
Participant Nr.: 10